Latest Breaking News On - Christine edry seidman - Page 1 : comparemela.com

TN-201 Received Fast Track Designation from the FDA Dosing Complete in Phase 1 Clinical Trial of TN-301; Data Expected in Second Half 2023 Renowned Researchers Drs. Christine Seidman and Alex Marson. | May 10, 2023

United statesWendy ryanMark angelinoChristine seidmanAngela thedingaChristine edry seidmanFaraz aliAlexander marsonGuangping gaoResearch development rd expensesGlobenewswire incCorporate communicationsAmerican society of geneProgram updatesTenaya therapeutics incBridge communications